当前位置：
X-MOL 学术
›
Cell. Mol. Immunol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Electrostatic complementarity of B-cell receptor CDR3s and TP53-mutant amino acids in breast cancer is associated with increased disease-free survival rates.
Cellular & Molecular Immunology ( IF 24.1 ) Pub Date : 2019-11-15 , DOI: 10.1038/s41423-019-0328-8 Juan F Arturo 1 , Boris I Chobrutskiy 1 , Michelle Yeagley 1 , Dhruv N Patel 1 , Shayan Falasiri 1 , Jay S Patel 1 , George Blanck 1, 2
中文翻译：
乳腺癌中B细胞受体CDR3和TP53突变氨基酸的静电互补性与无病生存率提高相关。
更新日期：2019-11-15
Cellular & Molecular Immunology ( IF 24.1 ) Pub Date : 2019-11-15 , DOI: 10.1038/s41423-019-0328-8 Juan F Arturo 1 , Boris I Chobrutskiy 1 , Michelle Yeagley 1 , Dhruv N Patel 1 , Shayan Falasiri 1 , Jay S Patel 1 , George Blanck 1, 2
Affiliation
|
中文翻译：
乳腺癌中B细胞受体CDR3和TP53突变氨基酸的静电互补性与无病生存率提高相关。
京公网安备 11010802027423号